One Stop Shop For Reports One Stop Shop For Reports
  • All Reports
  • All Sectors
  • Report Library
  • Who Trust Us
  • inquiry@market.us
  • +1 718 618 4351 (International)
  • +91 78878 22626 (Asia)

More Results

One Stop Shop For Reports One Stop Shop For Reports
  • All Reports
  • All Sectors
  • Report Library
  • Who Trust Us
Home » Companies » Agilent Technologies Inc. Company Profile

Agilent Technologies Inc. Company Profile

logo

Agilent Technologies, Inc.

Electronics

  • Type

    Public

  • Headquarters

    The US

  • Founded

    1999

  • Key Management

    Mr. Michael R McMullen (CEO)

  • Revenue

    ~6,319(October 2021)

  • Headcountz

    ~17,000(October 2021)

  • Website

    www.agilent.com

Business Description

Agilent Technologies, Inc. provides application-focused solutions for the life sciences, diagnostics, as well as applied chemical markets. The company’s headquarters is located in Santa Clara, CA. It was founded in 1999. It has software and instruments that enable it to analyze and determine the biological and physical properties and compositions of substances and products. Genomics and Diagnostics are active pharmaceutical ingredients that can also be used in Oligo-based therapeutics and solutions, which include consumables and reagents. Agilent CrossLab includes consulting and services, as well as software-as-a-service, asset management, compliance, training, and startup support.

Key Financials

Revenue (US$ Mn):

  • Agilent Technologies, Inc.’s annual revenue for 2021 was US$ 6,319 Mn, an 18.36% increase from 2020
  • The annual revenue generated by Agilent Technologies, Inc. in 2020 was US$ 5,339 Mn
  • At a 5.07% increase from , Agilent Technologies, Inc.’s annual revenue of US$ 5,163 Mn was indexed in 2019
  • Agilent Technologies, Inc. generated total revenue of US$ 4,914 Mn in 2018

 

Operating Income (US$ Mn):

  • Agilent Technologies, Inc.’s operating income for 2021 was US$ 1,347 Mn, a 59.22% increase from 2020
  • The operating income generated by Agilent Technologies, Inc. in 2020 was US$ 846 Mn
  • At a 1.4% increase from , Agilent Technologies, Inc.’s operating income of US$ 941 Mn was indexed in 2019
  • Agilent Technologies, Inc. generated an operating income of US$ 928 Mn in 2018

 

Net Income (US$ Mn):

  • US$ 1,210 Mn was the net income generated by Agilent Technologies, Inc. in 2021
  • Agilent Technologies, Inc.’s net income for 2020 was US$ 719 Mn, a -32.87% decrease from 2019
  • From 2018’s net incomes, Agilent Technologies, Inc. registered a 238.92% increase in 2019, amounting to US$ 1,071 Mn
  • A net income of US$ 316 Mn was generated in 2018 by Agilent Technologies, Inc.

 

Operating Margin %:

  • Agilent Technologies, Inc.’s operating margin for 2021 was 21%, a 34.81% increase from 2020
  • The operating margin generated by Agilent Technologies, Inc. in 2020 was 16%
  • At a -3.7% decrease from , Agilent Technologies, Inc.’s operating margin of 18% was indexed in 2019
  • Agilent Technologies, Inc. generated an operating margin of 19% in 2018

 

Gross Margin %:

  • 54% was the gross margin generated by Agilent Technologies, Inc. in 2021
  • Agilent Technologies, Inc.’s gross margin for 2020 was 53%, a -2.21% decrease from 2019
  • From 2018’s gross margins, Agilent Technologies, Inc. registered a -0.73% decrease in 2019, amounting to 54%
  • A gross margin of 55% was generated in 2018 by Agilent Technologies, Inc.

SWOT Analysis

Strength

A strong focus on R&D leads to new product development

Agilent Technologies Research Labs (Research Labs) is a company-owned research organization. It is based in Santa Clara, California. It also has offices in Europe, Asia, and the United States. The company’s R&D expenses were US$441million in FY2021, which was 7% of its revenue. A number of patents, licenses, and other intellectual rights have been registered by the company, or are pending registration. These rights protect company inventions and discoveries from infringement.

Get this premium content

The Premium data is Locked
Buy Now to Unlock Premium Data

 

Table of Content

  1. Business Description
  2. Key Financials
  3. SWOT Analysis
    1. Strength
      1. Strong focus on R&D leads to new product development
      2. Expanded market reach through diversifying geographical presence
      3. Revenue growth allows a company to pursue growth
    2. Weaknesses
      1. Dependence on contract manufacturing and outsourcing may affect the company’s ability to bring products to market
    3. Opportunities
      1. Strategic initiatives to foster growth opportunities
      2. A positive outlook for the global pharmaceutical industry
      3. Global genetic market
    4. Threats
      1. Intense competition
      2. Stringent government regulations
      3. Counterfeit products
    5. Key Developments
      1. Year 2022
      2. Year 2021
      3. Year 2020
  • US $299
  • US $499
Buy Now
✖

Request For Company Data

We'll get back to you as quickly as possible

Primary Sidebar

  • Facebook Logo
  • Twitter Logo
  • LinkedIn Logo
auto undefined
af Afrikaanssq Albanianam Amharicar Arabichy Armenianaz Azerbaijanieu Basquebe Belarusianbn Bengalibs Bosnianbg Bulgarianca Catalanceb Cebuanony Chichewazh-CN Chinese (Simplified)zh-TW Chinese (Traditional)co Corsicanhr Croatiancs Czechda Danishnl Dutchen Englisheo Esperantoet Estoniantl Filipinofi Finnishfr Frenchfy Frisiangl Galicianka Georgiande Germanel Greekgu Gujaratiht Haitian Creoleha Hausahaw Hawaiianiw Hebrewhi Hindihmn Hmonghu Hungarianis Icelandicig Igboid Indonesianga Irishit Italianja Japanesejw Javanesekn Kannadakk Kazakhkm Khmerko Koreanku Kurdish (Kurmanji)ky Kyrgyzlo Laola Latinlv Latvianlt Lithuanianlb Luxembourgishmk Macedonianmg Malagasyms Malayml Malayalammt Maltesemi Maorimr Marathimn Mongolianmy Myanmar (Burmese)ne Nepalino Norwegianps Pashtofa Persianpl Polishpt Portuguesepa Punjabiro Romanianru Russiansm Samoangd Scottish Gaelicsr Serbianst Sesothosn Shonasd Sindhisi Sinhalask Slovaksl Slovenianso Somalies Spanishsu Sundanesesw Swahilisv Swedishtg Tajikta Tamilte Teluguth Thaitr Turkishuk Ukrainianur Urduuz Uzbekvi Vietnamesecy Welshxh Xhosayi Yiddishyo Yorubazu Zulu
Find Help
  • Contact Us
  • How to Order
Legal
  • Privacy Policy
  • Refund Policy
  • Frequently Asked Questions
  • Terms and Conditions
Explore
  • About Us
  • All Reports
  • All Sectors
  • Infographics
  • Statistics and Facts
  • Companies
  • Report Library

© 2025 Market.Us. All Rights Reserved.